| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |